Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®)
Condition(s):Chronic Myeloid LeukemiaLast Updated:September 28, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Myeloid LeukemiaLast Updated:September 28, 2023Completed
Condition(s):Chronic Myelogenous Leukemia; Short StatureLast Updated:July 17, 2013Unknown status
Condition(s):Chronic Phase Philadelphia Positive; BCR-ABL Positive; Chronic Myeloid LeukaemiaLast Updated:January 5, 2022Unknown status
Condition(s):Folate; CML; Treatment-free RemissionLast Updated:January 3, 2022Unknown status
Condition(s):Chronic Myeloid LeukemiaLast Updated:April 14, 2011Terminated
Condition(s):Chronic Myelogenous LeukemiaLast Updated:October 5, 2023Recruiting
Condition(s):LeukemiaLast Updated:January 7, 2020Unknown status
Condition(s):Chronic Myeloid LeukemiaLast Updated:May 24, 2022Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:March 21, 2019Unknown status
Condition(s):Chronic Myeloid LeukemiaLast Updated:January 18, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.